Chuck Royce's PRAX Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 6,544 shares of Praxis Precision Medicines, Inc. (PRAX) worth $2.19 M, representing 0.02% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Chuck Royce has initiated a new position in PRAX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Praxis Precision Medicines (PRAX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Praxis Precision Medicines (PRAX) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +6,544 | New Buy | 6,544 | $334.79 |
Chuck Royce's Praxis Precision Medicines Investment FAQs
Chuck Royce first purchased Praxis Precision Medicines, Inc. (PRAX) in Q2 2026, acquiring 6,544 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Praxis Precision Medicines, Inc. (PRAX) for 1 quarters since Q2 2026.
Chuck Royce's largest addition to Praxis Precision Medicines, Inc. (PRAX) was in Q2 2026, adding 6,544 shares worth $2.19 M.
According to the latest 13F filing for Q2 2026, Chuck Royce's firm, Royce & Associates Lp, owns 6,544 shares of Praxis Precision Medicines, Inc. (PRAX), valued at approximately $2.19 M.
As of the Q2 2026 filing, Praxis Precision Medicines, Inc. (PRAX) represents approximately 0.02% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Praxis Precision Medicines, Inc. (PRAX) was 6,544 shares, as reported at the end of Q2 2026.